MCLE
Medicale Corp.Company with tickers: MCLE
CIK
1827855
CUSIP
58464K102
Shares Outstanding
5,920,000
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $3,144 | USD | 2025-12-31 | 10-Q | 2026-02-17 |
| Research & Development | — | ||||
| Operating Income | $-3,144 | USD | 2025-12-31 | 10-Q | 2026-02-17 |
| Net Income | $-5,290 | USD | 2025-12-31 | 10-Q | 2026-02-17 |
| EPS (Basic) | $0.00 | USD/shares | 2025-12-31 | 10-Q | 2026-02-17 |
| EPS (Diluted) | $0.00 | USD/shares | 2025-12-31 | 10-Q | 2026-02-17 |